News
Innovation & Change: Personnel Shifts in Stone Medicine Series
Recently, Sinopharm Group's subsidiary, Sinopharm Innovation Pharmaceuticals (Xinnova), announced that the board of directors has received written resignation reports from Chairman Pan Weidong and Dir...